Work

Development of Novel Microfluidic-based Pancreatic-Cancer-on-a-Chip Models

Year: 2023
Type: dissertation
Abstract: Pancreatic Ductal Adenocarcinoma (PDAC) shows mortality rates of up to 93%, as it is often detected at a late stage. Only 20% of the tumors are resectable, and therefore 80% of cases must be treated with either chemotherapeutics or immunotherapies. Nevertheless, chemotherapies usually only prolong the patient`s life for a few months and immunotherapies remain ineffective. The high-density stroma, which induces hypoxic conditions and high interstitial pressure, plays a major role in treatment resistance. These factors impact carcinogenesis and support the formation of an immunosuppressive microenvironment. Current platforms used to study PDAC often lack important features of the complex in vivo situation. Models, that incorporate stromal elements, including pancreatic stellate cells (PSCs), extracellular matrix (ECM), and immune cells, as well as in vivo like culture conditions are urgently needed to study these treatments and the potential causes of failures. Here, a model for testing chemotherapy treatment on PDAC organoids including PSCs as stromal compartment and hypoxia was established. The cells were subjected to Gemcitabine in combination with compounds targeting specific pathways under normoxic and hypoxic conditions. Gene expression analysis revealed different genetic programs of cells grown in the two oxygen conditions, that could explain treatment specific responses. Two groups of treatment responders were identified, showing either a better effect in monoculture or co-culture and between normoxia and hypoxia. In addition, the challenge of the different culture setups with Hypoxia-inducible factor (HIF) prolyl hydroxylase (PHD) inhibitor led to a significant increase in cell survival. This study highlights the importance of adjusting experimental conditions to in vivo like conditions and thus to include relevant oxygen levels. Moreover, it also indicates the relevance of direct HIF inhibitors or PHD enhancers as single or combination treatment for PDAC patients, that could be used in the future. In addition, to gain new insights about the effects of the complex tumor microenvironment (TME) in PDAC, a new model was created. This was employed to investigate the role of the endothelium and the stroma in immune migration as well as applying the model as a screening platform for stromal targeting as a potential treatment strategy. Within one model, immune cells attached to the endothelial tube, extravasated from the vessel to the stroma, and migrated towards the tumor cells. The role of the stroma could be divided into a physical barrier, that shields the cancer cells from migrating immune cells, as well as a biochemical barrier, leading to attraction of immune cells towards PSCs. This thesis focuses on the establishment and application of PDAC-on-a chip models to recreate the TME and its influence on treatment responses. These 3D tumor models could be used for both, fundamental as well as preclinical research.
Author: Marlene Geyer
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W7028017470
Cites: 125
Cited by: 1
Related to: 10